Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Kimbell Royalty Partners LP Units | KRP | Nov 27, 2024 | 16.00 | +0.63 |
Kimberly-Clark | KMB | Nov 27, 2024 | 139.20 | -0.38 |
Kimco Realty | KIM | Nov 27, 2024 | 25.78 | +1.26 |
Kimco Realty L Pref | KIM-L | Nov 27, 2024 | 22.23 | +1.04 |
Kimco Realty M Pref | KIM-M | Nov 27, 2024 | 22.62 | +0.22 |
Kimco Realty Pref ADR | KIM-N | Nov 27, 2024 | 62.78 | +0.19 |
Kinder Morgan | KMI | Nov 27, 2024 | 28.07 | -0.07 |
Kindercare Learning Companies | KLC | Nov 27, 2024 | 23.27 | 0.00 |
Kindly MD | KDLY | Nov 27, 2024 | 1.08 | -42.86 |
Kinetik A | KNTK | Nov 27, 2024 | 58.66 | -0.85 |
Kingsoft Cloud ADR | KC | Nov 27, 2024 | 7.01 | +17.42 |
Kingstone Companies | KINS | Nov 27, 2024 | 15.95 | -0.06 |
Kingsway Financial Services | KFS | Nov 27, 2024 | 8.87 | +0.11 |
Kiniksa Pharmaceuticals | KNSA | Nov 27, 2024 | 22.32 | +1.27 |
Kinross Gold | KGC | Nov 27, 2024 | 9.80 | -1.80 |
Kinsale Capital Group | KNSL | Nov 27, 2024 | 515.45 | +0.67 |
Kiora Pharmaceuticals | KPRX | Nov 27, 2024 | 3.57 | +3.53 |
Kirby | KEX | Nov 27, 2024 | 126.36 | -2.64 |
Kirklands | KIRK | Nov 27, 2024 | 1.75 | +2.34 |
Kite Realty Group Trust | KRG | Nov 27, 2024 | 27.85 | +0.18 |
KKR & Co | KKR | Nov 27, 2024 | 160.03 | -0.77 |
KKR Income Opportunities Fund | KIO | Nov 27, 2024 | 13.37 | +0.68 |
KKR Real Estate Finance Trust | KREF | Nov 27, 2024 | 11.69 | +0.43 |
KKR Real Estate Finance Trust A Pref | KREF-A | Nov 27, 2024 | 21.13 | +0.72 |
KLA | KLAC | Nov 27, 2024 | 632.14 | +0.11 |
Klaviyo | KVYO | Nov 27, 2024 | 36.60 | -1.37 |
KLD 400 Social Index Ishares | DSI | Nov 27, 2024 | 113.60 | -0.52 |
Klotho Neurosciences | KLTO | Nov 27, 2024 | 0.34 | 0.00 |
KLX Energy Services | KLXE | Nov 27, 2024 | 6.02 | +0.17 |
Knife River | KNF | Nov 27, 2024 | 102.75 | -1.75 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.